Synthroid Sales Data
| Rank 83 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Synthroid U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 83 ( 5) |
$200,695 | 5.21% | 2,484 | 1.22% |
| Q4 2012 | 88 (2) |
$190,754 | 2.63% | 2,454 | -0.04% |
| Q3 2012 | 90 (7) |
$185,868 | 12.61% | 2,455 | 4.96% |
| Q2 2012 | 97 ( ) |
$165,049 |  |
2,339 | |
| Q3 2011 | 95 (4) |
$160,078 | -0.04% | 2,712 | 6.60% |
| Q2 2011 | 99 () |
$160,142 | |
2,544 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
